한글목차

철결핍성 빈혈 치료의 동향과 예측

세계의 철결핍성 빈혈 치료 시장은 2024-2030년의 CAGR이 5.3%로, 2030년까지 추정 46억 달러에 달할 것으로 예상되고 있습니다. 이 시장의 주요 촉진요인은 식품으로부터의 철섭취 부족과 적혈구의 과도 감소에 기인하는 철결핍성 빈혈의 높은 발생률, 특히 여성과 어린이에게 영향을 미치는 것, 여성 인구의 급증, 여성 건강에 대한 의식의 향상입니다. 세계의 철결핍성 빈혈 치료 시장의 미래는 병원, 진료소, 재택의료 시장에서의 기회로 유망해 보입니다.

철결핍성 빈혈 치료 시장 인사이트

Lucintel은 재조합 에리스로포이에틴 요법을 받고 있는 환자 및 경구 수단에 의한 철 흡수를 방해하는 만성질환을 앓고 있는 환자의 수요가 높기 때문에 비경구 철요법이 예측 기간 중 최대 부문을 유지할 것으로 예측하고 있습니다.

이 시장에서 병원은 복잡한 증례를 처리하는 설비가 갖추어지고, 환자를 관리하기 위해 필요한 시설과 스탭을 갖추고 있으므로 앞으로도 최대 부문을 유지할 것입니다.

북미는 헬스케어비의 급증, 국민 사이에서 철결핍성 빈혈의 유병률 증가 및 이 지역에서 주요 시장 기업의 존재에 의해 예측 기간 중 최대 지역을 유지할 것으로 예상됩니다.

자주 묻는 질문

Q1.시장 규모는? :

A1.세계의 철결핍성 빈혈 치료 시장은 2030년까지 추정 46억 달러에 달할 것으로 예상되고 있습니다.

Q2.시장의 성장 예측은? :

A2.세계의 철결핍성 빈혈 치료 시장은 2024-2030년 CAGR 5.3%로 성장할 것으로 예상되고 있습니다.

Q3.시장의 성장에 영향을 미치는 주요 촉진요인은? :

A3.이 시장의 주요 촉진요인은 식품으로부터의 철섭취 부족과 적혈구의 과도 감소에 기인하는 철결핍성 빈혈의 높은 발생률, 특히 여성과 어린이에게 영향을 미치는 것, 여성 인구의 급증, 여성 건강에 대한 의식의 향상입니다.

Q4.시장의 주요 부문은? :

A4.세계의 철결핍성 빈혈 치료 시장의 미래는 병원, 진료소, 재택의료 시장에서의 기회로 유망해 보입니다.

Q5.시장의 주요 기업은? :

A5.주요 철결핍성 빈혈 치료 회사는 다음과 같습니다.

• Abbvie
• Akebia Therapeutics
• AMAG Pharmaceuticals
• Daiichi Sankyo
• Pharmacosmos
• Sanofi
• Johnson and Johnson
• Fresenius
• ViforPharma
• Rockwell Medical

Q6.향후 최대가 되는 시장 부문은? :

A6.Lucintel은 재조합 에리스로포이에틴 요법을 받고 있는 환자 및 경구 수단에 의한 철 흡수를 방해하는 만성질환을 앓고 있는 환자의 수요가 높기 때문에 비경구 철요법이 예측 기간 중 최대 부문을 유지할 것으로 예측하고 있습니다.

Q7.시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은? :

A7.북미는 헬스케어비의 급증, 국민 사이에서 철결핍성 빈혈의 유병률 증가 및 이 지역에서 주요 시장 기업의 존재에 의해 예측 기간 중 최대 지역을 유지할 것으로 예상됩니다.

Q8.리포트의 커스터마이즈는 가능한가? :

A8.네, Lucintel은 추가 비용 없이 10%의 커스터마이즈를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 철결핍성 빈혈 치료 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018-2030년의 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 철결핍성 빈혈 치료 시장의 동향(2018-2023년)과 예측(2024-2030년)
• 치료법별 세계의 철결핍성 빈혈 치료 시장
  • 경구 철요법
  • 비경구 철요법
  • 적혈구 수혈
• 최종 용도별 세계 철결핍성 빈혈 치료 시장
  • 병원
  • 진료소
  • 재택의료

제4장 2018-2030년의 지역별 시장 동향과 예측 분석

• 지역별 세계의 철결핍성 빈혈 치료 시장
• 북미의 철결핍성 빈혈 치료 시장
• 유럽의 철결핍성 빈혈 치료 시장
• 아시아태평양의 철결핍성 빈혈 치료 시장
• 기타 지역의 철결핍성 빈혈 치료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 치료법별 세계의 철결핍성 빈혈 치료 시장의 성장 기회
  • 최종 용도별 세계 철결핍성 빈혈 치료 시장의 성장 기회
  • 지역별 세계의 철결핍성 빈혈 치료 시장의 성장 기회
• 세계의 철결핍성 빈혈 치료 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 철결핍성 빈혈 치료 시장의 능력 확대
  • 세계의 철결핍성 빈혈 치료 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Abbvie
• Akebia Therapeutics
• AMAG Pharmaceuticals
• Daiichi Sankyo
• Pharmacosmos
• Sanofi
• Johnson and Johnson
• Fresenius
• ViforPharma
• Rockwell Medical

영문목차

Iron Deficiency Anemia Therapy Trends and Forecast

The future of the global iron deficiency anemia therapy market looks promising with opportunities in the hospital, clinic, and home healthcare markets. The global iron deficiency anemia therapy market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.3% from 2024 to 2030. The major drivers for this market are high incidence of iron deficiency anemia is attributed to insufficient iron intake from food and excessive loss of red blood cells, particularly affecting women and children, surge in female population, and growing awareness towards women health.

A more than 150-page report is developed to help in your business decisions.

Iron Deficiency Anemia Therapy by Segment

The study includes a forecast for the global iron deficiency anemia therapy by therapy type, end use, and region.

Iron Deficiency Anemia Therapy Market by Therapy Type [Shipment Analysis by Value from 2018 to 2030]:

• Oral Iron Therapy
• Parenteral Iron Therapy
• Red Blood Cell Transfusion

Iron Deficiency Anemia Therapy Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Home Healthcare

Iron Deficiency Anemia Therapy Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Iron Deficiency Anemia Therapy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies iron deficiency anemia therapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the iron deficiency anemia therapy companies profiled in this report include-

• Abbvie
• Akebia Therapeutics
• AMAG Pharmaceuticals
• Daiichi Sankyo
• Pharmacosmos
• Sanofi
• Johnson and Johnson
• Fresenius
• ViforPharma
• Rockwell Medical

Iron Deficiency Anemia Therapy Market Insights

Lucintel forecasts that parenteral iron therapy will remain the largest segment over the forecast period due to high demand for patients receiving recombinant erythropoietin therapy or suffering from chronic diseases that hinder iron absorption through oral means.

Within this market, hospital will remain the largest segment as it is equipped to handle complex cases and has necessary facilities and staffs to manage patients.

North America will remain the largest region over the forecast period due to surge in healthcare spending, increasing prevalence of iron deficiency anemia among the population, and the presence of key market players in the region.

Features of the Global Iron Deficiency Anemia Therapy Market

Market Size Estimates: Iron deficiency anemia therapy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Iron deficiency anemia therapy market size by therapy type, end use, and region in terms of value ($B).

Regional Analysis: Iron deficiency anemia therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapy types, end uses, and regions for the iron deficiency anemia therapy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the iron deficiency anemia therapy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the iron deficiency anemia therapy market size?

Answer: The global iron deficiency anemia therapy market is expected to reach an estimated $4.6 billion by 2030.

Q2. What is the growth forecast for iron deficiency anemia therapy market?

Answer: The global iron deficiency anemia therapy market is expected to grow with a CAGR of 5.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the iron deficiency anemia therapy market?

Answer: The major drivers for this market are high incidence of iron deficiency anemia is attributed to insufficient iron intake from food and excessive loss of red blood cells, particularly affecting women and children, surge in female population, and growing awareness towards women health.

Q4. What are the major segments for iron deficiency anemia therapy market?

Answer: The future of the global iron deficiency anemia therapy market looks promising with opportunities in the hospital, clinic, and home healthcare markets.

Q5. Who are the key iron deficiency anemia therapy market companies?

Answer: Some of the key iron deficiency anemia therapy companies are as follows:

• Abbvie
• Akebia Therapeutics
• AMAG Pharmaceuticals
• Daiichi Sankyo
• Pharmacosmos
• Sanofi
• Johnson and Johnson
• Fresenius
• ViforPharma
• Rockwell Medical

Q6. Which iron deficiency anemia therapy market segment will be the largest in future?

Answer: Lucintel forecasts that parenteral iron therapy will remain the largest segment over the forecast period due to high demand for patients receiving recombinant erythropoietin therapy or suffering from chronic diseases that hinder iron absorption through oral means.

Q7. In iron deficiency anemia therapy market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surge in healthcare spending, increasing prevalence of iron deficiency anemia among the population, and the presence of key market players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the iron deficiency anemia therapy market by therapy type (oral iron therapy, parenteral iron therapy, and red blood cell transfusion), end use (hospitals, clinics, and home healthcare), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Iron Deficiency Anemia Therapy Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Iron Deficiency Anemia Therapy Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Iron Deficiency Anemia Therapy Market by Therapy Type
  • 3.3.1: Oral Iron Therapy
  • 3.3.2: Parenteral Iron Therapy
  • 3.3.3: Red Blood Cell Transfusion
• 3.4: Global Iron Deficiency Anemia Therapy Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Clinics
  • 3.4.3: Home Healthcare

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Iron Deficiency Anemia Therapy Market by Region
• 4.2: North American Iron Deficiency Anemia Therapy Market
  • 4.2.2: North American Iron Deficiency Anemia Therapy Market by End Use: Hospitals, Clinics, and Home Healthcare
• 4.3: European Iron Deficiency Anemia Therapy Market
  • 4.3.1: European Iron Deficiency Anemia Therapy Market by Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, and Red Blood Cell Transfusion
  • 4.3.2: European Iron Deficiency Anemia Therapy Market by End Use: Hospitals, Clinics, and Home Healthcare
• 4.4: APAC Iron Deficiency Anemia Therapy Market
  • 4.4.1: APAC Iron Deficiency Anemia Therapy Market by Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, and Red Blood Cell Transfusion
  • 4.4.2: APAC Iron Deficiency Anemia Therapy Market by End Use: Hospitals, Clinics, and Home Healthcare
• 4.5: ROW Iron Deficiency Anemia Therapy Market
  • 4.5.1: ROW Iron Deficiency Anemia Therapy Market by Therapy Type: Oral Iron Therapy, Parenteral Iron Therapy, and Red Blood Cell Transfusion
  • 4.5.2: ROW Iron Deficiency Anemia Therapy Market by End Use: Hospitals, Clinics, and Home Healthcare

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Iron Deficiency Anemia Therapy Market by Therapy Type
  • 6.1.2: Growth Opportunities for the Global Iron Deficiency Anemia Therapy Market by End Use
  • 6.1.3: Growth Opportunities for the Global Iron Deficiency Anemia Therapy Market by Region
• 6.2: Emerging Trends in the Global Iron Deficiency Anemia Therapy Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Iron Deficiency Anemia Therapy Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Iron Deficiency Anemia Therapy Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbvie
• 7.2: Akebia Therapeutics
• 7.3: AMAG Pharmaceuticals
• 7.4: Daiichi Sankyo
• 7.5: Pharmacosmos
• 7.6: Sanofi
• 7.7: Johnson and Johnson
• 7.8: Fresenius
• 7.9: ViforPharma
• 7.10: Rockwell Medical